Katy Beckermann/medschool.vanderbilt.edu
Apr 20, 2025, 02:48
Katy Beckermann: New Paper in Nature Cancer – UnitedMet Enables Metabolic Profiling from RNA-Seq
Katy Beckermann, Medical Director of GU Clinical Research at Tennessee Oncology, posted on X:
“Exciting new paper in Nature Cancer: UnitedMet—a Bayesian model that imputes metabolite levels from RNA-seq data, enabling metabolic profiling without direct metabolite measurements.
Congrats Ed Reznik and Wesley Tansey on this exciting work.
Highlights:
- Joint modeling of RNA-seq + metabolomics
- Histology-associated metabolic differences across RCC subtypes
- BAP1 mutations in ccRCC linked to oxidative metabolic phenotype
- Enables metabolomic inference without needing direct measurements
A cool new way to go from genotype metabolism.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 19:44
May 9, 2025, 19:25
May 9, 2025, 18:51
May 9, 2025, 18:03